Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma

Clinical trial NCT00396864 · COMPLETED

Trial details

NCT number: NCT00396864
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Lymphomas

Start date: 2006-05-01
Primary completion: 2010-03-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.